Table 4 Multiple regression analysis of plasma XOR† activity in hemodialysis patients with and without type 2diabetes mellitus (DM).

From: Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients

 

Patients without type 2 DM

Patients with type 2 DM

β

p

Model 1

Model 2

β

p

β

p

Age

0.064

0.490

−0.026

0.810

0.001

0.999

Gender

0.128

0.150

0.083

0.453

0.012

0.917

Dialysis duration

−0.113

0.215

−0.057

0.598

−0.192

0.091

Urea nitrogen

−0.112

0.263

0.123

0.324

0.091

0.459

Alanine transaminase

0.562

<0.001

0.373

0.001

0.378

0.001

Uric acid

0.200

0.042

−0.063

0.594

−0.028

0.819

Plasma glucose

0.094

0.298

0.363

0.001

—

—

Glycated albumin

—

—

—

—

0.330

0.004

R2

0.395 (p < 0.001)

0.301 (p < 0.001)

0.273 (p = 0.003)

  1. * p < 0.05, †XOR: xanthine oxidoreductase.
  2. β: standardized correlation coefficient, R2: multiple coefficient of determination.
Back to article page